Treadmill exercise slows cognitive deficits in aging rats by antioxidation and inhibition of amyloid production

NeuroReport

Volumn 24, Issue 6, 2013, Pages 342-347

  Yu, Feng ^a,b   Xu, Bo ^a,b   Song, Chenghui ^c   Ji, Liu ^a,b   Zhang, Xianliang ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

amyloid b 42; D galactose; learning and memory; malondialdehyde; rat; superoxide dismutase; treadmill exercise

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; GALACTOSE; MALONALDEHYDE; MESSENGER RNA; PROTEIN A DISINTEGRASE AND METALLOPROTEASE DOMAIN 17; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REPRESSION; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY; MENTAL PERFORMANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREADMILL EXERCISE; UPREGULATION;

ADAM PROTEINS; AGING; AMYLOID; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIOXIDANTS; ASPARTIC ACID ENDOPEPTIDASES; BLOTTING, WESTERN; COGNITION; GALACTOSE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; PEPTIDE FRAGMENTS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RUNNING; SUPEROXIDE DISMUTASE;

EID: 84875860572     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283606c5e     Document Type: Article

References (25)

1. Van Praag H, Shubert T, Zhao C, Gage FH. Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 2005; 25:8680-8685. (Pubitemid 41362045)
2. Kim SE, Ko IG, Kim BK, Shin MS, Cho S, Kim CJ, et al. Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus. Exp Gerontol 2010; 45:357-365.
3. Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25:4217-4221. (Pubitemid 40628765)
4. Wolf SA, Kronenberg G, Lehmann K, Blankenship A, Overall R, Staufenbiel M, et al. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol Psychiatry 2006; 60:1314-1323. (Pubitemid 44838527)
5. Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce Ab deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 2007; 88:277-294. (Pubitemid 47321221)
6. Liu HL, Zhao G, Cai K, Zhao HH, Shi LD. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1transgenic mice through improvement of hippocampal long-term potentiation. Behav Brain Res 2011; 218:308-314.
7. Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, et al. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease. Neurosci Res 2011; 69:161-173.
8. Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, et al. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 2009; 35:426-432.
9. Mirochnic S, Wolf S, Staufenbiel M, Kempermann G. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 2009; 19:1008-1018.
10. Um HS, Kang EB, Leem YH, Cho IH, Yang CH, Chae KR, et al. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int J Mol Med 2008; 22:529-539.
11. Young YD, Kim W, Lee CH, Shin BN, Nam SM, Choi JH, et al. Melatonin improves D-galactose-induced aging effects on behavior, neurogenesis, and lipid peroxidation in the mouse dentate gyrus via increasing pCREB expression. J Pineal Res 2012; 1:21-28.
12. Kumar A, Prakash A, Dogra S. Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by D-galactose in mice. Food Chem Toxicol 2010; 48:626-632.
13. Zhang Q, Li X, Cui X, Zuo P. D-galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res 2005; 27:552-556. (Pubitemid 41040845)
14. Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 2004; 95:233-238. (Pubitemid 39056283)
15. Chiu CS, Deng JS, Hsieh MT, Fan MJ, Lee MM, Chueh FS, et al. Yam (Dioscorea pseudojaponica Yamamoto) ameliorates cognition deficit and attenuates oxidative damage in senescent mice induced by D-galactose. Am J Chin Med 2009; 37:889-902.
16. Zhang XL, Jiang B, Li ZB, Hao S, An LJ. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav 2007; 88:64-72. (Pubitemid 47379823)
17. Vassar R, Kovacs DM, Yan R,Wong PC. The b-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential. J Neurosci 2009; 29:12787-12794.
18. Hampel H, Shen Y. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease. Scand J Clin Lab Invest 2009; 69:8-12.
19. Skovronsky DM, Fath S, Lee VM, Milla ME. Neuronal localization of the TNF converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J Neurobiol 2001; 49:40-46.
20. Anderson BJ, Rapp DN, Baek DH, McCloskey DP, Coburn-Litvak PS, Robinson JK. Exercise influences spatial learning in the radial arm maze. Physiol Behav 2000; 70:425-429.
21. Adlard PA, Perreau VM, Christie EC, Cotman CW. The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci Lett 2004; 363:43-48. (Pubitemid 38639848)
22. Bandyopadhyay S, Goldstein LE, Lahiri DK, Rogers JT. Role of the APP nonamyloidogenic signaling pathway and targeting a-secretase as an alternative drug target for treatment of Alzheimer's disease. Curr Med Chem 2007; 14:2848-2864. (Pubitemid 350201652)
23. Lauderback CM, Hackett JM, Huang F, Keller JM, Szweda L, Markesbery WR, et al. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Ab (1-42). J Neurochem 2001; 78:413-416. (Pubitemid 32664423)
24. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002; 32:1050-1060. (Pubitemid 34603342)
25. Somani SM, Ravi R, Rybak LP. Effect of exercise training on antioxidant system in brain regions of rat. Pharmacol Biochem Behav 1995; 50: 635-639.